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Abstract Anti-inflammatory transcriptional effects of
nineteen compounds (1–19) from the soft coral Sinularia
maxima were evaluated using NF-jB luciferase and reverse
transcriptase polymerase chain reaction. Compounds 1, 2,
4, 8, 15, 17, and 18 significantly inhibited TNFa-induced
NF-jB transcriptional activity in HepG2 cells in a dose-
dependent manner, with IC50 values ranging from
15.81 ± 2.29 to 29.10 ± 1.54 lM. Furthermore, the tran-
scriptional inhibitory function of these compounds was
confirmed by a decrease in intercellular adhesion molecule-
1 and inducible nitric oxide synthase gene expression
levels in HepG2 cells. These results provide a scientific
rationale for the use of the soft coral S. maxima warrant
further studies to develop new agents for the prevention
and treatment of inflammatory.
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Introduction
Activation of nuclear factor kappa B (NF-jB) represents a
family of Rel domain-containing proteins including five
NF-jB units that can form 15 transcription factors through
homo- and heterodimerization (Baldwin 2001a). NF-jB
plays an important role in the transcriptional regulation of
numerous cytokines and adhesion molecules. It is arguably
the most important transcription factor for the initiation or
progression of numerous human diseases (Mattson and
Camandola 2001). As a ubiquitous transcription factor
governing the expression of viruses or a variety of
inflammatory cytokine genes, NF-jB was first implicated
in the pathogenesis of human immunodeficiency virus-1
(HIV-1) infection (Nabel and Baltimore 1987). NF-jB, a
nuclear transcription factor, regulates the expression of
various genes, including cytokines, iNOS, COX-2 and
ICAM-1, which play critical roles in apoptosis, autoim-
mune diseases, and inflammation (Albert and Baldwin
1996). Further studies suggest that activation of NF-jB is
responsible for the pathological progression of neurological
disorders, carcinogenesis, immune deficiency, rheumatoid
arthritis, atherogenesis, Crohn’s disease, cystic fibrosis,
asthma, osteopetrosis, ischemic reperfusion, etc. (Chen
et al. 1999).
Among the Alcyonacean soft corals, genus Sinularia is
one of the most widely distributed soft coral genera, con-
stituting a dominant portion of the biomass in the tropical
reef environment (Lakshmi and Kumar 2009). Previous
studies have indicated that diterpenes, a main constituent of
the genus Sinularia, exhibit various biological activities,
such as anti-inflammatory (Chao et al. 2011; Cheng et al.
2010; Lu et al. 2010; Su and Wen 2011), antiviral (Cheng
et al. 2010), and cytotoxic (Grote et al. 2008; Kamel et al.
2007; Lo et al. 2009; Su et al. 2009) effects. As a part of
our ongoing investigations on screening active compounds
from Vietnamese Sinularia soft corals towards anti-
inflammatory effects (Thao et al. 2012, 2013a, b), we
recently reported the isolation, structure elucidation, and
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inhibitory effects on lipopolysaccharide-stimulated pro-
duction of proinflammatory cytokines in bone marrow-
derived dendritic cells of 12 diterpenoids [sinumaximol A
(1), sinumaximol B (2), sinumaximol C (3), sethukarailin
(4), sinumaximol D (5), sinumaximol E (6), sinumaximol F
(7), sinumaximol G (8), sinumaximol H (9),
(1S,2E,4S,6E,8S,11R)-2,6,12(20)-cembratriene-4,8,11-triol
(10), isomandapamate (11), and sinumaximol I (12)] (Thao
et al. 2012) and 7 norditerpenoids [scabrolide A (13),
12-hydroxy-scabrolide A (14), yonarolide (15), ineleg-
anolide (16), 5-epinorcembrene (17), 13-epi-scabrolide C
(18), and norcembrene 5 (19)] (Thao et al. 2013a) from
Sinularia maxima (see Fig. 1). The current study provides
new insight into the ways by which diterpenoids and nor-




The sample of soft coral S. maxima was collected at
Nhatrang Bay, in November in 2010 and identified by Prof.
Do Cong Thung (Institute of Marine Environment and
Resources, VAST). A voucher specimen (SM112010_01)
was deposited at the Institute of Marine Biochemistry and
Institute of Marine Environment and Resources, VAST.
Cell culture and reagents
Human hepatocarcinoma HepG2 cells were maintained in
Dulbecco’s modified Eagle’s medium (Invitrogen, Carls-
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Fig. 1 Structure of compounds 1–19 from the soft coral Sinularia maxima
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bovine serum, 100 units/mL penicillin, and 10 lg/mL
streptomycin at 37 C and 5 % CO2. Human TNFa was
purchased from ATgen (Seoul, Korea). Cells were counted
with a hemocytometer, and the number of viable cells was
determined through trypan blue dye exclusion.
Cytotoxicity assay
A 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphe-
nyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS)
assay (CellTiter 96 AQueous One Solution Assay, Pro-
mega, Madison, WI, USA) was performed to analyze the
effect of the different compounds on cell viability. Cells
were cultured overnight in 96-well plates (1 9 104 cells
per well). Cell viability was assessed after the incubation
with the compounds at a concentration of 10 lM for 24 h.
The number of viable cells was determined by measuring
the absorbance at 490 nm of the dissolved formazan
product after addition of MTS for 30 min as described by
the manufacturer.
NF-jB and iNOS-luciferase assay
The luciferase vector was first transfected into HepG2
cells. After a limited amount of time, the cells were lysed
and luciferin, the substrate of luciferase, was introduced
into the cellular extract along with Mg2? and an excess of
ATP. Under these conditions, luciferase enzymes expres-
sed by the reporter vector could catalyze the oxidative
carboxylation of luciferin. Cells were seeded at 1.5 9 105
cells per well in a 12-well plate and grown for 24 h. All
cells were transfected using LipofectamineTM LTX
(Invitrogen) according to the manufacturer’s protocol.
Luciferase (Luc) activity was assayed using an LB 953
Autolumat (EG&G Berthold, Nashua, NH, USA) as
described previously (Kim et al. 2010). NF-jB-Luc was
kindly provided by Dr. Kyoon E. Kim (Chungnam National
University, Daejeon, Korea). The transfected HepG2 cells
were pretreated for 1 h with either vehicle (DMSO) and
compounds, followed by 1 h of treatment with 10 ng/mL
TNFa. Unstimulated HepG2 cells were used as a negative
control (-). Cells were then harvested, and luciferase
activity was assayed. All experiments were performed in
triplicate.
RNA preparation and RT-PCR
HepG2 cells were pretreated in the absence and presence of
compounds for 1 h, then exposed to 10 ng/mL TNFa for
6 h. Total mRNA was prepared from the cell pellets using
Easy-blue. The levels of mRNA were assessed by reverse
transcriptase polymerase chain reaction (RT-PCR) (Quang
et al. 2012).
Total RNA was extracted from cells using easy-BLUETM
(iNtRON Biotechnology, Seoul). Approximately 2 lg of total
RNA was reverse-transcribed using Moloney murine leukemia
virus reverse transcriptase and oligo (dT) primers (Promega)
for 1 h at 42 C. The resulting cDNA was polymerase chain
reaction-amplified using Taq polymerase premixture (TaKa-
Ra, Shiga, Japan). Polymerase chain reaction products were
subjected to electrophoresis on 1 % agarose gels and stained
with ethidium bromide. Polymerase chain reaction was con-
ducted with the following primer pairs: iNOS sense 50-TCAT
CCGCTATGCTGGCTAC-30, iNOS antisense 50-CTCAGGG
TCACGGCCATTG-30, ICAM-1 sense 50-GCCCAGCACTT
CACGCATCAG-30, ICAM-1 antisense 50-GACCAGGCA
CCAGACCAAAGACC-30, glyceraldehyde 3-phosphate de-
hydrogenase sense 50-TGTTGCCATCAATGACCCCTT-30,
and glyceraldehyde 3-phosphate dehydrogenase antisense
50CTCCACGACGTACTCAGCG-30. b-actin sense 50-TCAC
CCACACTGTGCCCATCTACG-30, and b-actin antisense
50-CAGCGGAACCGCTCATTGCCAATG-30.
Statistical analysis
All results are expressed as mean±SD values. Data were
analyzed by one-factor analysis of variance. Quantification
of polymerase chain reaction products was performed using
Image LabTM software (Bio-Rad). If a statistically signifi-
cant effect was found, the Newman–Keuls test was per-
formed to isolate the difference between the groups.
P \ 0.5 was considered to be significant.
Results
To investigate cellular toxicity of the compounds 1–19, they
were applied at various concentrations to HepG2 cells for
24 h, after which cell viability was measured in an MTS
assay as described in Materials and methods. None of the
compounds displayed any cellular toxicity at the concen-
tration of 10 lM (data not shown). They were therefore used
in subsequent experiments for further evaluation of their
effects on NF-jB activation, iNOS and ICAM-1 expressions
at concentrations of 0.1, 1.0 and 10 lM (see Fig. 4).
To evaluate the anti-inflammatory activity of nineteen
compounds listed above, we first examined their inhibitory
effects on NF-jB transcriptional activation in HepG2 cells
(see Figs. 2, 3). Cells were treated with compounds at
various concentrations prior to stimulation with TNFa
(10 ng/mL). Among compounds tested, 1, 2, 4, 8, 15, 17,
and 18 were found to have effect on the inhibition of NF-
jB activation with 50 % inhibition concentration (IC50)
values ranging from 15.81 ± 2.29 to 29.10 ± 1.54 lM.
Other compounds exhibited moderate, weak or not deter-
mined activities (Table 1).
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Discussion
NF-jB was first described in 1986 as a nuclear transcrip-
tion factor required for immunoglobulin kappa light chain
transcription in B-cells. Since its discovery, it has been
demonstrated that NF-jB is constitutively expressed in all
cell types and plays a central role as a regulator of the
cellular stress response. The NF-jB-mediated signaling
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Fig. 2 Effects of compounds 1–9 on tumor necrosis factor-a (TNFa)-
induced nuclear transcription factor jB activation in HepG2 cells.
HepG2 cells transiently transfected with pNF-jB-luciferase were
pretreated for 1 h with vehicle (dimethyl sulfoxide-DMSO) or one of
the compounds, prior to 1 h of treatment with TNFa (10 ng/mL).
Unstimulated HepG2 cells acted as a negative control. Cells were
then harvested, and luciferase activities were assessed. Results are
expressed as relative luciferase activity. Sulfasalazine was used as a
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Fig. 3 Effects of compounds 10–19 on tumor necrosis factor-a
(TNFa)-induced nuclear transcription factor jB activation in HepG2
cells. HepG2 cells transiently transfected with pNF-jB-luciferase
were pretreated for 1 h with vehicle (dimethyl sulfoxide-DMSO) or one
of the compounds, prior to 1 h of treatment with TNFa (10 ng/mL).
Unstimulated HepG2 cells acted as a negative control. Cells were then
harvested, and luciferase activities were assessed. Results are expressed
as relative luciferase activity. Sulfasalazine was used as a positive
(Pos.) control. Data are mean–SD values (n = 3). P \ 0.5 versus
control
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pathway has been considered both pro-inflammatory and
anti-apoptotic in character, and therefore, has been impli-
cated in the pathogenesis of a wide variety of diseases,
including inflammatory disorders and tumor development
(Robinson and Mann 2010). As previously demonstrated,
activation of NF-jB has been linked to multiple patho-
physiological conditions such as cancer, arthritis, asthma,
inflammatory bowel disease, and other inflammatory con-
ditions (Baldwin 2001b). It can be activated by various
stimuli, such as microbial and viral products, cytokines,
DNA damage, and noxious chemicals. The induction of
several pro-inflammatory mediators occurs as a result of
increased inducible nitric oxide synthase (iNOS) and
cyclooxygenase-2 (COX-2) activities (Surha et al. 2001).
NF-jB and the signaling pathways that regulate many
physiological processes, including innate and adaptive
immune responses, cell death, and inflammation, have
become a focal point for intense drug discovery and
development efforts (Chung et al. 2007; Perkins 2007).
Indeed, increasing evidence has validated NF-jB as a
target for anti-inflammatory and anticancer agents.
To date, the inhibition of components from S. maxima
on NF-jB transcriptional activation has not been evaluated.
In this study, the effects of compounds 1–19 on TNFa-
induced NF-jB transcriptional activity in HepG2 cells
were evaluated using a NF-jB luciferase assay. To confirm
their inhibitory effects of the compounds on NF-jB tran-
scriptional activity, the effects of the isolated compounds
on the upregulation of the pro-inflammatory proteins iNOS
and ICAM-1 were assessed in TNFa-stimulated HepG2
cells by RT-PCR.
HepG2 cells were first transfected with NF-jB lucifer-
ase reporter plasmids. After treatment with 10 ng/mL
Table 1 Effects of compounds 1–19 on NF-jB luciferase activity in
HepG2 cells
Compound IC50 values (lM)
1 21.35 ± 3.21
2 29.10 ± 1.54
3 40.49 ± 2.07
4 25.81 ± 1.38
5 50.42 ± 2.11
6 ND
7 60.33 ± 0.88
8 15.81 ± 2.29
9 ND
10 224.05 ± 5.89
11 325.71 ± 4.77
12 40.42 ± 2.11
13 75.22 ± 3.66
14 45.12 ± 1.75
15 25.1 ± 2.58
16 ND
17 28.19 ± 2.65
18 20.13 ± 0.29
19 84.80 ± 4.34
Positive controla 0.90 ± 0.20
IC50 50 % inhibition concentration, ND not determined
a Sulfasalazine was used as positive control compound
Fig. 4 Inhibitory effects of
compounds 1–19 on TNFa-
induced expression of inducible
nitric oxide synthase (iNOS)
and intercellular adhesion
molecule-1 (ICAM-1) mRNAs
in HepG2 cells. Effects of
compounds 1, 2, 4, 8, 15, 17 and
18 on ICAM-1 and iNOS
mRNA expression in HepG2
cells were assessed. HepG2
cells were pretreated with one of
the listed compounds for 1 h
and then treated with TNFa
(10 ng/mL) for 6 h. Total
mRNAs were prepared from the
cell pellets using easy-BLUETM
(iNtRON Biotechnology, Seoul)
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TNF-a, luciferase activity increased fivefold, demonstrat-
ing an increase in transcriptional activity compared to
untreated cells. Compounds were pretreated with trans-
fected HepG2 cells at various concentrations, followed by
stimulation with TNFa. The results showed that com-
pounds 1, 2, 4, 8, 15, 17, and 18 significantly inhibited
TNFa-induced NF-jB transcriptional activation in a dose-
dependent manner with IC50 values of 21.35 ± 3.21,
29.10 ± 1.54, 25.81 ± 1.38, 15.81 ± 2.29, 25.1 ± 2.58,
28.19 ± 2.65, 20.13 ± 0.29 lM, respectively (see Figs. 2,
3). Compounds 3, 10–14, and 19 exhibited moderate or
weak inhibitory effects with IC50 values ranging from
40.42 ± 2.11 to 325.71 ± 4.77 lM, whereas other com-
pounds were inactive at the indicated concentrations,
compared with the positive control (see Table 1).
NF-jB activation is known to be involved in the
upregulation of inflammatory NF-jB target gene expres-
sion, including iNOS and ICAM-1, which play important
roles in the inflammatory response. iNOS is highly
expressed in macrophages, leading to organ destruction in
some inflammatory and autoimmune diseases (Kleinert
et al. 2004). ICAM-1 (CD54) is a 90-kDa inducible cell-
surface glycoprotein that promotes leukocyte adhesion in
inflammatory conditions (Rothlein et al. 1986; Springer
1990). Analysis of the ICAM-1 complementary deoxyri-
bonucleic acid sequence has revealed it to be a member of
the immunoglobulin gene superfamily (Staunton et al.
1988). ICAM-1 is expressed basally at low levels on many
cell types, including endothelial cells, macrophages, myo-
cytes, and vascular smooth muscle cells, but can be
induced to high levels by stimulation with LPS, phorbol
ester, or inflammatory cytokines, such as TNF-a or inter-
leukin-1b (Colic and Drabek 1991; Ruetten et al. 1999).
To confirm the transcriptional inhibitory function of
compounds 1, 2, 4, 8, 15, 17, and 18; we further investi-
gated their effects on ICAM-1 and iNOS gene expression
in TNFa-stimulated HepG2 cells using RT-PCR. Consis-
tent with their inhibitory activity toward NF-jB, com-
pounds 1, 2, 4, 8, 15, 17, and 18 significantly inhibited the
induction of ICAM-1 and iNOS mRNA in a dose-depen-
dent manner (see Fig. 4), indicating that these compounds
reduced transcription of these genes. Moreover, the
housekeeping protein b-actin was unchanged by the pres-
ence of compounds 1, 2, 4, 8, 15, 17, and 18 at the same
concentration (see Fig. 4). Our data suggest that com-
pounds 1, 2, 4, 8, 15, 17, and 18 isolated from the soft coral
S. maxima have therapeutic potential as anti-inflammatory,
anti-atherosclerotic, and anti-arthritic substances. How-
ever, elucidation of the detailed mechanisms underlying
the inhibition of the TNFa-induced NF-jB pathway and
subsequent decreases in ICAM-1 and iNOS gene expres-
sion by compounds 1, 2, 4, 8, 15, 17, and 18 requires
further investigation.
Consideration of the structure–activity relationship of
these compounds indicated that the ketone groups at C-3
and/or C-6, the hydroxyl group at C-7 and/or C-8 are
necessary for the anti-inflammatory activity of diterpenoids
and norditerpenoids. This finding was confirmed by com-
paring the structure and activity of compounds 1, 2, 4, 8,
15, 17, and 18, therefore this information may facilitate
identification of anti-inflammatory lead compounds from
diterpenoids and norditerpenoids. This primary finding
provides support for further studies on these compounds for
the development of anti-inflammatory agents.
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